Screener
Iovance Biotherapeutics, Inc. IOVA Price / book
Price / book at other companies
Other financials
Where this comes from
Calculated from Iovance Biotherapeutics, Inc.’s reported figures.
Based on the most recent quarter.
The source filing: Iovance Biotherapeutics, Inc.’s 10-Q, filed August 6, 2026. Open the filing →
- Filed
- Aug 6, 2026, 9:15 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001104659-26-091716
FAQ
- What is Iovance Biotherapeutics, Inc.'s price / book?
- Iovance Biotherapeutics, Inc. (IOVA) reported price / book of 2.5× in Q2 2026.
- How has Iovance Biotherapeutics, Inc.'s price / book changed year-over-year?
- Iovance Biotherapeutics, Inc.'s price / book increased by 180.8% year-over-year, from 0.9× to 2.5×.
- What is the long-term trend for Iovance Biotherapeutics, Inc.'s price / book?
- Over 5 years (2020 to 2025), Iovance Biotherapeutics, Inc.'s price / book has grown at a -31.7% compound annual growth rate (CAGR), from 10.4× to 1.6×.
- What does price / book mean?
- Market capitalization at the quarter end divided by shareholders' equity. The premium (or discount) the market assigns to the company's book equity.
Ask your AI about Iovance Biotherapeutics, Inc.'s price / book.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude